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1136-80 Postconditioning by Repetitive I/R Cycles Subsequent 
to Myocardial Ischemia Protects the Rat Heart From 
Infarction and Is Dependent on the Activation of PI 3-
Kinase and mTOR
Christof Weinbrenner, Claudia Reußner, Susanne Sütterlin, László Sárváry, Ruth H. 
Strasser, University of Technology, Dresden, Germany
Background: Ischemic preconditioning (pre-C) is a powerful mechanism in reducing the
infarct size of the heart. Recently it was found in an in situ dog model that postcondition-
ing (post-C) by repetitive ischemia/reperfusion (I/R) cycles after infarction may be protec-
tive and may reduce the infarct size.
Objective and methods: To address the question, whether post-C may be as protective
as pre-C infarct size was determined in isolated perfused rat hearts. To test whether post-
C is dependent on the signaling of PI 3-kinase/protein kinase B (Akt), wortmannin,
LY294002 and rapamycin were used to inhibit PI 3-kinase or mTOR, a signaling molecule
downstream of Akt, respectively.
Results: Control hearts (60 min regional ischemia followed by 2 hours of reperfusion)
had an infarct size of 64±6% whereas pre-C (three cycles 5 min I/R each preceding the
60 min of infarction) reduced it to 15±3% of the risk zone (p<0.001). Post-C induced by
three cycles of 30 sec I/R each starting immediately after the onset of reperfusion follow-
ing the 60 min of infarction also reduced the infarct size significantly to 28±5% (p<0.001
vs. control). Statistically this was not significantly different from pre-C. 0.1 µM wortmannin
or LY294003, both PI 3-kinase inhibitors, which were given during the 60 min of infarction
and the first 10 min of reperfusion, completely blocked the protection from post-C
(61±7%, 67±5%, resp.; p<0.001 vs. post-C). 0.1 µM rapamycin also blocked the protec-
tion of post-C (51±4%, p<0.01 vs. post-C) albeit this inhibition was not as complete as
with the PI 3-kinase inhibitors.
Conclusion: Protection of the heart from infarction is possible either through preceding
(pre-C) or subsequent (post-C) I/R stimuli. Post-C is nearly as protective as pre-C regard-
ing the protection of the myocardium. Post-C depends on the activation of PI 3-kinase
and partially on mTOR suggesting the involvement of PI 3-kinase/Akt as survival path-
way. The additional components involved in the signal transduction pathway of post-C,
however, have to be determined. Post-C offers fascinating clinical possibilities for the
therapy of myocardial infarction since the patient with infarction presents not prior but
after the onset of infarction.
1136-81 Epsilon Protein Kinase C (PKC) Activation by Delta PKC 
in Ethanol-Induced Cardiac Protection From Ischemia
Koichi Inagaki, Daria Mochly-Rosen, Stanford University School of Medicine, Stanford, 
CA
Background: Previous studies have demonstrated that acute ethanol exposure induces
activation of δ Protein kinase C (PKC) and εPKC, and mimics ischemic preconditioning
via εPKC activation. However, the role of εPKC isozyme in ischemia/reperfusion is still
controversial. Here, we investigated the role of δPKC in ethanol-induced cardioprotection
using a δPKC-selective activator (ψδRACK), a selective inhibitor (δV1-1), and an εPKC-
selective inhibitor (εV1-2) in isolated mouse hearts.
Methods: Mice were injected intraperitoneally with 0.5g/kg of ethanol or ψδRACK, and
saline, δV1-1 or εV1-2 before ischemia. Mouse hearts were then subjected to a 30-
minute global ischemia and a 120-minute reperfusion, ex vivo.
Results: Ethanol treatment 60 minutes, but not 10 minutes, before ischemia reduced inf-
arct size and CPK release. Pretreatment with εV1-2 completely inhibited ethanol-induced
cardioprotection. Pretreatment with δV1-1 induced cardioprotection when mice were
injected with ethanol 10 minutes before ischemia, but δV1-1 partly inhibited ethanol-
induced cardioprotection when mice were injected with ethanol 60 minutes before
ischemia. ψδRACK injection 60 minutes, but not 10 minutes, before ischemia induced
cardioprotection and this cardioprotection was completely inhibited by pretreatment with
εV1-2. Furthermore, ψδRACK induced the translocation of εPKC from the cytosol to the
particulate fraction 60 minutes, but not 10 minutes, before ischemia, in vivo. However, in
isolated cardiomyocytes, ψRACK treatment did not induce translocation of εPKC.
Conclusions: Treatment with ethanol (0.5g/kg) or δPKC activator induces cardioprotec-
tion against ischemia/reperfusion one hour, but not immediately before ischemia. Etha-
nol-induced δPKC activation confers cardioprotection via εPKC activation one hour after
treatment. δPKC-induced εPKC activation may be mediated by soluble factors released
from non-cardiomyocytes.
1136-82 Tetrahydrobiopterin Depletion Leads to Endothelial 
Nitric Oxide Synthase Dysfunction in Ischemic Hearts
Yong Xia, Roberto Biondi, Tiebaud Liebgott, Nazareno Paolocci, AJ Cardounel, 
Giuseppe Ambrosio, Jay L. Zweier, University of Perugia School of Medicine, Perugia, 
Italy, Johns Hopkins School of Medicine, Baltimore, MD
Background: Endothelial nitric oxide synthase (eNOS) function is impaired in ischemic
hearts. However, the mechanism of this impairment is unclear. eNOS activity requires
availability of cofactors such as tetrahydrobiopterin (BH4). It has been shown that lack of
BH4 contributes to eNOS dysfunction in hypercholesterolemia and hypertension. Yet,
whether decreased BH4 is involved in ischemia-induced eNOS dysfunction is unclear.
Methods: We evaluated changes in BH4 content and eNOS activity in rat hearts sub-
jected to 30, 45 or 60 min global ischemia at 37°C. BH4 content was measured on car-
diac homogenate by HPLC using electrochemical detection; eNOS activity was assayed
by L-[14C] arginine to L-[14C] citrulline conversion.
Results: Ischemia led to a dramatic decrease in BH4 content within 30 min; this loss was
paralleled by a substantial and progressive reduction in eNOS activity (Table). To investi-
gate whether decreased eNOS activity was causally related to BH4 depletion, in parallel
experiments eNOS activity was measured in presence of an excess (10 µM) exogenous
BH4. BH4 addition substantially restored eNOS activity when ischemia was limited to 30
min (Table); no increase in eNOS activity was observed in presence of BH4 after longer
time of ischemia (45 and 60 min).
Conclusions: Our data show that ischemia induces a major loss in cardiac BH4 content,
and that eNOS activity is critically anchored to BH4 bioavailability in this setting. Supple-
mentation with exogenous BH4 may partially restore eNOS function 
1136-83 Simulated Ischemia/Reperfusion Promotes Akt 
Phosphorylation via Both Redox-Sensitive and 
Insensitive Mechanisms in H9c2 Cells
Tai-Hwang M. Fan, Zhe Jiao, Emory University/Atlanta VA Medical Center, Atlanta, GA
Background: Akt is a serine/threonine kinase that has been shown to play key regula-
tory roles in many physiological processes including glucose metabolism, cell prolifera-
tion and migration, and cell survival against apoptosis. The paradigm for activation of Akt
involves phosphatidylinositol 3-kinase (PI3K)-dependent membrane localization followed
by phosphorylation of two critical residues, Ser473 near the carboxyl terminus and
Thr308 in the activation loop. In this study, we examined the effects of simulated
ischemia/reperfusion (I/R) on Akt in cardiac cells. We hypothesized that reactive oxygen
species production during reperfusion is a prerequisite for phosphorylation to occur at
each of the two phosphorylation sites. Methods: H9c2 cells, derived from embryonic
heart tissue, were used for the study. Simulated ischemia was induced by incubating the
cells in an “ischemic medium” placed in an air-tight anaerobic chamber purged with
95%N2/5% CO2. Following 3 hr of “ischemia,” cells were “reperfused” with maintenance
culture medium for 1 hr. Site-specific Akt phosphorylation was evaluated by Western
analysis using phospho-specific antibodies against Ser473 phospho-Akt and Thr308
phospho-Akt. Results: Ischemia alone induced a selective decrease in Ser473 phospho-
Akt levels (58% reduction compared to normoxic controls, p<0.05) without affecting
Thr308 phosphorylation. Reperfusion caused both Ser473 and Thr308 phospho-Akt lev-
els to increase without affecting total Akt levels. The effect of I/R on Ser473 phosphoryla-
tion and Thr308 phosphorylation was completely blocked by pretreatment of the cells
with the PI3K inhibitor wortmannin (100 nM). In contrast, pretreatment of the cells with
the antioxidant N-acetyl-cysteine (2 mM) significantly blunted the effect of I/R on Thr308
phosphorylation without affecting Ser473 phosphorylation. Conclusion: In H9c2 cells, I/
R promotes phosphorylation of Akt at both Ser473 and Thr308 in a PI3K-dependent man-
ner. While the phosphorylation of Thr308 (presumably by the action of PDK1, the
upstream kinase of Akt) is redox-sensitive, autophosphorylation of Akt at Ser473 appears
to be redox-insensitive.
1136-84 Time-Dependent Upregulation of Extracellular Matrix 
Proteins in Chronic Hibernating Myocardium: Lack of 
Progressive Degeneration
Vijay S. Iyer, Gen Suzuki, Juliette M. Hardy, Brendan M. Heavey, James A. Fallavollita, 
John M. Canty, Jr., University at Buffalo, Buffalo, NY, VA Medical Center, Buffalo, NY
Background: Biopsies from hibernating myocardium have led to divergent conclusions
regarding the role of adaptation vs. degeneration. The latter is inferred from upregulation
of ECM proteins that may negatively impact functional recovery. We tested the hypothe-
sis that ECM protein expression is an early event that normalizes in the adapted state.
Methods: Swine (n=12) were chronically instrumented with 1.5 mm LAD stenoses to
produce hibernating myocardium. RNA was isolated from flash frozen subendocardial tis-
sue and hybridized for cDNA microarray analysis at 3 (n=6) or 5 months (n=6) after
instrumentation.
Results: Physiological features of hibernating myocardium were no different at 3 vs 5
months and there was no functional or pathological evidence of progressive deteriora-
tion. Subendocardial flow (LAD 0.8 ± 0.1 vs. 1.2 ± 0.1 ml/min/g, p<0.01) and wall thicken-
ing (LAD 2.4 ± 0.5 vs. 5.9 ± 0.5 mm, p<0.01) were reduced in comparison with normal
regions. Expression of ECM proteins was time dependent (Table). ECM proteins includ-
ing collagen, fibronectin, and vimentin were initially upregulated in hibernating LAD
regions. After 5 months, the expression of ECM proteins decreased to levels that were
similar to normal regions.
Conclusions: The normalization of ECM genes after 5 months is consistent with the sta-
bility of connective tissue demonstrated by pathology. Thus, divergent clinical conclu-
sions regarding adaptation vs. structural degeneration reflect time-dependent alterations
in remodeling.
BH4 content and eNOS activity at baseline and during ischemia (mean±SE of 5 
experiments)
Baseline 30 min 
ischemia
45 min 
ischemia
60 min 
ischemia
BH4 (pmol/mg) 2.51±0.51 0.45±0.09* 0.38±0.05* 0.31±0.14*
eNOS (pmol/min/mg) 0.16±0.02 0.08±0.01* 0.04±0.01* 0.03±0.01*
eNOS after exogenous 
BH4 (pmol/min/mg)
0.27±0.02 0.24±0.01 0.11±0.01* 0.04±0.01*
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1136-85 Ischemic Preconditioning Increases Heat Shock 
Protein-72 Protein Expression and Reduces Elevation of 
Creatine Kinase-MB Following Coronary Artery Bypass 
Graft in Humans
Christian Vahlhaus, Joachim Neumann², Tonny D. Tjan³, Frauke Janssen³, Hans H. 
Scheld³, Wilhelm Schmitz², Günter Breithardt, Thomas Wichter, University of Muenster, 
Muenster, Germany
Background: Ischemic preconditioning, ie, the reduction of infarct size development dur-
ing prolonged and severe myocardial ischemia by one or more preceding short episodes
of ischemia and reperfusion, is the most powerful endogenous cardioprotective effect.
We investigated whether a stress activated signal-transduction via heat shock protein 72
(HSP-72) mediated phopshorylation of p38 Mitogen activated protein kinase (MAPK) is
involved in the creatine kinase-MB (CKMB) release reducing effect of ischemic precondi-
tioning in patients undergoing CABG.
Methods: According to the ischemic episodes within 24-48 hours before CABG patients
with angina CCS III or IV were classified as preconditioned (IP, n=9), whereas patients
with angina CCS I or II formed the control group (CON, n=10). The effect of IP on the
CABG induced maximal CKMB-release was examined. Biopsies from ischemic and con-
trol regions in each patient were processed to analyse protein expression of HSP-72 and
the calcium handling proteins phospholamban (PL), sarcoendoplasmic Ca-ATPase 2a
(SERCA), calsequestrin (CSQ), the inhibitory subunit of troponin (TnI) and phosphoryla-
tion of MAPK.
Results: IP reduced CKMB (18.7±1.3 vs. 13.8±1.5 U/L, CON vs. IP, mean±SD, p=0.02).
Results of biopsy specimens are depicted in table 1 (relative changes of *protein expres-
sion and #MAPK-phosphorylation).
Conclusion: Cardioprotection during CABG can be improved with IP. Possible mecha-
nisms are the induced expression of HSP-72 and/or SERCA.
1136-86 Protein Kinase C Epsilon Is Upstream and Protein 
Kinase C Alpha Is Downstream of MitoKATP Channels 
in the Signaling of Ischemic Preconditioning in the 
Human Myocardium
Ashraf Hassouna, Bashir M. Matata, Manuel Galiñanes, University of Leicester, 
Leicester, United Kingdom
Background: PKC is part of the signal transduction of ischemic preconditioning (IPC)
but the PKC isoforms involved and their relation to mitoKATP channels is unclear. Meth-
ods: Right atrial muscles from patients undergoing cardiac surgery were sectioned and
after equilibration were randomized to receive one of the following protocols: aerobic con-
trol (A/C), simulated ischemia for 90 min and reoxygenation for 120 min (SI/R), IPC using
5 min SI/ 5 min R and the following inhibitors were added 10 min before and during IPC:
V1-2 peptide [10 µM], GO6976 [100 nM], Rottlerin [100 µM], and LY333531 [100 nM] for
PKCε, α, δ, β respectively. To investigate the location of the PKC isoforms involved in IPC
in relation to mitoKATP channels, PKC α and ε inhibitors were added 10 min before and
during preconditioning by Diazoxide (DXZ)[100 µM] in a second experiment. CK leakage
and MTT cell viability were measured. Phosphorylation of PKC isoforms were measured
using immunoblots after treatment with IPC or DXZ. Results: In Fig, PKCε and α inhibi-
tors blocked IPC whereas PKCδ and β inhibitor did not. The protection elicited by
mitoKATP channels opening with DXZ was blocked by the inhibition by PKCα but not by
inhibition of PKCε isoforms. The MTT values mirrored the CK results. In addition, DXZ
caused increased phosphorylation of PKCα similar to IPC but failed to cause significant
increase of PKCε phosphorylation. Conclusion: Both PKCε and α are involved in IPC of
the human myocardium with PKCε upstream and PKCα downstream of mitoKATP chan-
nels.
1136-87 Remote Preconditioning by Infrarenal Occlusion of the 
Aorta Protects the Rat Heart From Infarction by a 
Molecular Mechanism Involving Free Radicals and a p38 
Mitogen Activated Protein Kinase Activation
Christof Weinbrenner, Alexander Werschy, Falk Schulze, Ruth H. Strasser, University of 
Technology, Dresden, Germany
Background: Ischemic preconditioning (PC) is a powerful mechanism in reducing the
infarct size of the heart. Protection can be provided either by an ischemic stimulus of the
heart itself (classical or orthotopic PC) or by ischemia of an organ distant to the heart
(remote or heterotopic PC).
Objective and methods: To address the question whether remote PC is dependent on
endogenously released free radicals and/or on an activation of p38 MAPK, infarct size
was determined in an in situ model of infrarenal occlusion of the aorta (IOA) in the rat
after pharmacological inhibition of free radicals or p38 MAPK.
Results: Control hearts (30 min regional ischemia followed by 30 min of reperfusion) had
an infarct size of 50±2%, whereas classical PC with one ischemia/reperfusion cycle (I/R)
reduced it to 21±4% and with three I/R cycles to 14±1% of the risk zone (p<0.001). 15
min IOA followed by a 10 min reperfusion period reduced the infarct size to 20±3%
(p<0.001 vs. control; p=0.051 vs. PC three I/R cycles).
20 mg/kg body weight MPG, a free radical scavenger, completely blocked the protection
obtained by IOA (46±3%, p<0.001 vs. IOA no MPG) as well as the one obtained by clas-
sical PC with one I/R cycle (43±4%, p<0.01 vs. PC one I/R cycle no MPG). Protection of
classical PC with three I/R cycles could, however, not be blocked (13±4%). MPG itself
had no influence on infarct size in control hearts (53±5%).
Using SB203580, a selective p38 MAPK-inhibitor, at a dose of 2 mg/kg body weight, pro-
tection by remote PC was blocked (46±3%, p<0.001 vs. IOA no SB) as well as by classi-
cal PC with three I/R cycles (42±4%, p<0.001 vs. PC no SB). Again SB itself had no
influence on infarct size in control hearts (47±3%).
Conclusion: Protection of the heart by heterotopic PC using IOA is nearly as powerful as
orthotopic preconditioning. Both protection methods share as common elements in their
signal transduction pathways free radicals and p38 MAPK. Since orthotopic PC by one I/
R cycle but not by three I/R cycles could be blocked by MPG, protection by orthotopic PC
is more robust than protection by heterotopic PC. The protecting substances, which are
located upstream of p38 MAPK, could be free radicals but remain to be characterized fur-
ther.
1136-88 The Polymorphisms C (-260) T in the Promoter Region 
of CD14 Receptor Gene and G (-174) C of Interleukin-6 
Gene Are Not Related to the Immune Response to 
Chlamydia Pneumoniae Infection and Heat Shock 
Protein-60 in Ischaemic Heart Disease
Giovanna Di Giannuario, Luigi M. Biasucci, Alessandra Ciervo, Giovanna Liuzzo, Matteo 
Santamaria, Maddalena Piro, Salvatore Brugaletta, Antonio Cassone, Antonio Cassone, 
Pierfranco Pignatti, Filippo Crea, Catholic University, Rome, Italy, Istituto Superiore 
Sanita', Rome, Italy
Background: The conflicting results on the role of Chlamydia pneumoniae (Cp) in
ischaemic heart disease might be related to modulation of individual response to Cp-
infection by genetic polymorphisms. The CD14 membrane receptor is a mediator for
monocyte activation by bacterial products, as lypopolysaccharide and Chlamydial Heat
Shock Protein 60 (HSP60Cp). Interleukin 6 is a pro-inflammatory cytokine stimulating B-
lymphocytes differentiation and antibody production. The aim of this study was to evalu-
ate if two functional genetic polymorphisms, the C (-260) T polymorphism in the promoter
region of the CD14 receptor gene and the G (-174) C polymorphism of interleukin 6
gene, are related to immune response to Cp in patients with IHD. Methods: we studied 51
patients with IHD. In all patients we measured serum levels of Antibody anti-HSP60Cp
(AbHSP60) (ELISA) and IgG anti Cp. The polymorphisms C (-260) T of CD14 receptor
gene and G (-174) C of Interleukin 6 gene were detected by polymerase chain reaction
and restriction analysis. Results: We did not find significant differences in AbHSP60
serum SD) among the C (-260) T polymorphisms of the CD14 receptor ± levels (AU;
mean 0.42, 0.63 ± gene: CC homozygotes, CT heterozygotes, and TT homozygotes
(0.66 0.46, respectively; p=ns). No differences were also found among the ± 0.37, 0.77 ±
three genotypes of G (-174) C Interleukin 6 gene polymorphism: GG homozygotes, 0.37,
± 0.42, 0.58 ± 0.37, 0.74 ± GC heterozygotes and CC homozygotes (0.62 respectively;
p=ns). IgG anti Cp levels (median, range), were not significantly different between the
three genotypes of C (-260) T CD14 receptor gene polymorphism, CC homozygotes, CT
heterozygotes and TT homozygotes (24, 0-128; 48, 0-256; 8, 0-32, respectively; p=ns)
and between the three genotypes of G (-174) C Interleukin 6 gene polymorphism: GG
Gene Hibernating LAD/normal
3 Months 5 Months
Collagen Type I
2.8 ± 0.7* 1.3 ± 0.2†
Collagen Type III 2.2 ± 0.5* 1.4 ±0.2
Collagen Type VI 1.5 ± 0.2* 0.9 ± 0.1†
Fibronectin 4.9 ± 2.7* 1.3 ± 0.2
Vimentin 1.8 ± 0.3* 1.2 ± 0.1†
GAPDH 0.9 ± 0.2 0.9 ± 0.1
*LAD vs. normal p<0.05; mean ± SEM
† 5 vs. 3 Months p< 0.05, Statistical Analysis of Microarray
Table 1: Biopsy specimens
mean±SD PL*  SERCA*  CSQ*  TnI*  HSP-72*  MAPK#
CON 0.24±0.12 -0.26±0.07 -0.09±0.04 -0.12±0.07 0.09±0.12 0.05±0.28
IP 0.06±0.35 0.33±0.19 -0.02±0.07 0.12±0.18 0.44±0.11 0.84±0.43
t-test: P 0.626 0.008 0.354 0.212 0.045 0.141
